Build status - In Progress

STRIDE Study : The Effects of semaglutide on functional capacity in pith type 2 diabetes and peripheral arterial disease

STRIDE Study : The Effects of semaglutide on functional capacity in pith type 2 diabetes and peripheral arterial disease
Recruiting
18 years - 99 years
All
Phase 3
10 participants needed
1 Location

Brief description of study

This is a 52 week, randomized, double-blind, placebo-controlled trial comparing semaglutide 1 mg versus placebo both added to standard of care and administered once weekly in subjects with Type 2 Diabetes Mellitus with Intermittent Claudication.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: type 2 diabetes,peripheral arterial disease,PAD,type 2 diabetes,peripheral arterial disease,PAD
  • Age: 18 years - 99 years
  • Gender: All

Male or Female Type 2 Diabetes 18 years of age or older peripheral arterial disease

Updated on 04 Aug 2024. Study ID: 848387

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center